Pfizer Canada Defeats Neupogen Patent Claims On Obviousness

Company Now Holds NOC For Nivestym Filgrastim Biosimilar

 
• By Dean Rudge
  
Canada_Thumbs_Up
Pfizer Canada has now been issued with an NOC for Nivestym, following setbacks • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin